Among these factors, MYCN proto-oncogene amplification, which is detected in about 20–30% of NB, is considered as the most reliable genomic hallmark of aggressive tumor behavior and treatment failure [3, 6, 8, 9]. Here, MYCN is linked to neuroblastoma.